跳至主要内容
临床试验/NCT02056041
NCT02056041已完成不适用

Selection Criteria for Safe Hepatectomy for Hepatocellular Carcinoma: Validation on 336 Consecutive Hepatectomies.

University of Milan1 个研究点 分布在 1 个国家目标入组 336 人开始时间: 2004年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
336
试验地点
1
主要终点
Safety of surgery for HCC

研究概览

简要总结

Selection criteria for safe hepatectomy for HCC are not well established. The aim of this study was the validation of the selection criteria for safe hepatectomy for hepatocellular carcinoma.

详细描述

All consecutive patients submitted to hepatectomy for HCC based on the same preoperative selection criteria from our prospectively-maintained liver unit database. Such criteria included the value of bilirubin (BIL), the value of cholinesterases (CHE), the presence of ascites, the presence of esophageal varices, and the rate of residual liver volume.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • any patient with HCC submitted to hepatic resection at our Unit in the established frame time

排除标准

  • any patient with missing data or lost at follow-up

结局指标

主要结局

Safety of surgery for HCC

时间窗: 90 days

The primary endpoint was the validation of our selection criteria for safe hepatectomy for HCC in regards to postoperative complications. The role of total bilirubin and cholinesterases was analzyed together with other clinical parameters.

次要结局

  • Score systems HCC(90 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Prof. Guido Torzilli

Professor of Surgery

University of Milan

研究点 (1)

Loading locations...

相似试验